• Title/Summary/Keyword: Technetium

Search Result 129, Processing Time 0.034 seconds

Renal Manifestations and Imaging Studies of Kawasaki Disease (가와사키 질환에서의 신증상과 영상 검사 소견)

  • Oh, Ji Young;Park, Se Jin;Kim, Sun Jung;Jang, Gwang-Cheon;Kim, Uria;Shin, Jae Il;Kim, Kee Hyuck
    • Childhood Kidney Diseases
    • /
    • v.17 no.2
    • /
    • pp.86-91
    • /
    • 2013
  • Purpose: The aim of this study was to verify renal inflammation following Kawasaki disease (KD) using single photon emission computed tomography along with Technetium-99m dimercaptosuccinic acid scintigraphy (DMSA renal SPECT). Methods: From March 2011 to October 2011, 15 patients diagnosed with KD at the National Health Insurance System Ilsan Hospital were enrolled in the study. All patients underwent DMSA renal SPECT to evaluate renal involvement during the acute phase of KD. Urine ${\beta}2$-microglobulin (${\beta}2$-MG), a marker of renal proximal tubular dysfunction, was also measured to assess renal damage. Results: All 15 patients had normal renal function test results. However, microscopic hematuria and pyuria were observed in 13% and 33% of the patients, respectively. Moreover, urine ${\beta}2$-MG was elevated in 46% of the patients. In addition, patients were divided into two groups based on ${\beta}2$-MG level: those with an increased ${\beta}2$-MG level, and those with a normal ${\beta}2$-MG level. No significant differences were found between these two groups in clinical characteristics, laboratory, sonography, and echocardiography findings. All patients' DMSA renal SPECT scans were normal. Conclusion: Our study showed that mild abnormalities in the urinalysis and elevated urine ${\beta}2$-MG were the only findings of renal involvement in KD. However, no aggressive renal manifestations were detected on DMSA renal SPECT.

Transcolonic scintigraphy for diagnosis of canine portosystemic shunts

  • Lee, Young-won
    • Korean Journal of Veterinary Research
    • /
    • v.39 no.2
    • /
    • pp.390-393
    • /
    • 1999
  • Transcolonic scintigraphy using $^{99m}Technetium$ pertechnetate ($^{99m}TcO_{4}$) was performed in 5 dogs with portosystemic shunts. In all dogs, the activity in the heart was seen before liver activity. Also time activity curve was revered. The mean shunt index in 5 dogs was 82.3% (range 79.6~87.1%). Transcolonic scintigraphy is quick, simple and useful diagnostic method for canine portosysternic shunts.

  • PDF

Design and Synthesis of Quipazine Based Re-Complexes for the Development of Potential SPECT Imaging Agents with 99m Tc for 5-HT Transporter

  • In, Mi-Young;Chi, Dae-Yoon;Choi, Sun-Ju;Park, Kyung-Bae;Cho, Cheon Gyu
    • Bulletin of the Korean Chemical Society
    • /
    • v.23 no.10
    • /
    • pp.1439-1444
    • /
    • 2002
  • 6-Nitroquipazine has higher binding affinity for SERT than other selective serotonin reuptake inhibitors. We have prepared 6-nitroquipazine based rhenium complexes which would lead to the development of potential SPECT imaging agents with $^{99m}Tc$ for 5-HT transporter.

Splenic Absorption of Radiopharmaceutical in Systemic Bone Scans Performed after Liver Transplantation

  • Sang-Hyeong Kil;Kyung-Nam Jo;Yung-Hyun Lim
    • The Korean Journal of Nuclear Medicine Technology
    • /
    • v.27 no.1
    • /
    • pp.4-6
    • /
    • 2023
  • Technetium-labeled phosphate bone scan was shown to detect bone fractures and bone metastasis in early stage than general radiographs. Therefore, bone scan has become one of the most frequently performed nuclear medicine imaging examination. However, non-osseous radiopharmaceutical uptake on the bone scan are unusual findings. We report a case of diffuse splenic absorption of Tc-99m dicarboxypropane diphosphonate in patients who undergo liver transplantation.

  • PDF

Lymphatic Delivery of $^{99m}Tc$-labeled Dextran Acetate Particles Including Cyclosporine A

  • Kim, Jin;Chung, Kyong-Hwan;Lee, Chang-Moon;Seo, Young-Soon;Song, Ho-Chun;Lee, Ki-Young
    • Journal of Microbiology and Biotechnology
    • /
    • v.18 no.9
    • /
    • pp.1599-1605
    • /
    • 2008
  • Biodistribution and lymphoscintigraphy of cyclosporine A (CyA) and technetium-99m ($^{99m}Tc$) were studied using ${^99m}Tc$-labeled dextran acetate (DxA) including CyA. DxA particles were prepared from dextran with acetic anhydride, and CyA was loaded into them. Lymphatic delivery of ${^99m}Tc$-labeled DxA particles containing CyA was evaluated after subcutaneous injection into the foot pad of rats and compared with those of ${^99m}Tc$-labeled human serum albumin (HSA). The labeling efficiency of CyA-loaded ${^99m}Tc$-DxA particles was about 95% at 30 min. The labeling efficiency maintained stably above 80% for 12 h. The percent injected dose (%ID) of CyA-loaded ${^99m}Tc$-DxA was similar to that of ${^99m}Tc$-HSA at the inguinal lymph node after 40 min. The CyA-loaded ${^99m}Tc$-DxA could be as well distributed as ${^99m}Tc$-HSA through the lymph node. The DxA particles could steadily distribute the CyA as well as the ${^99m}Tc$ radiolabeling through the lymph node.

Which Factors Related to the Renal Cortical Defects in Infants Under 3 Months of Age with Urinary Tract Infections?

  • An, Yu Kyung;Cho, Myung Hyun;Kim, Kyo Sun
    • Childhood Kidney Diseases
    • /
    • v.20 no.2
    • /
    • pp.57-62
    • /
    • 2016
  • Purpose: We used technetium-99m dimercaptosuccinic acid (DMSA) scintigraphy to identify factors predictive of renal cortical defects in infants <3 months of age with urinary tract infections (UTIs). Methods: We retrospectively reviewed data on infants <3 months of age with culture-proven UTIs treated at a single center from March 2010 to February 2016. Blood samples were obtained for laboratory evaluation prior to commencement of antibiotic therapy. The therapeutic delay time (TDT) and therapeutic response time (TRT) were recorded. All patients were divided into two groups depending on features of their DMSA scans. We compared the demographic, clinical, and laboratory characteristics of the two groups. Results: A total of 119 infants (94 males and 25 females; mean age, $56.9{\pm}21.3days$) were included. Cortical defects were evident in the DMSA scans of 47 cases (39.5%). In infants with such defects, the peak temperatures ($38.9{\pm}0.57^{\circ}C$ vs. $38.4{\pm}0.81^{\circ}C$, P=0.001), the absolute neutrophil counts ($8,920{\pm}4,460/mm$ vs. $7,290{\pm}4,090/mm$, P=0.043), and the C-reactive protein (CRP) levels ($6.49{\pm}4.33mg/dL$ vs. $3.21{\pm}2.81mg/dL$, P=0.001) were significantly higher than those in infants without cortical defects. The TDT was also longer in those with cortical defects (P=0.037). Conclusion: We found that a TDT ${\geq}8.5hr$ (odds ratio [OR] 5.81), a peak temperature ${\geq}38.3^{\circ}C$ (OR 6.19), and a CRP level ${\geq}4.96mg/dL$ (OR 7.26) predicted abnormal DMSA scan results in infants <3 months of age with UTIs.

Development of fission 99Mo production process using HANARO

  • Lee, Seung-Kon;Lee, Suseung;Kang, Myunggoo;Woo, Kyungseok;Yang, Seong Woo;Lee, Junsig
    • Nuclear Engineering and Technology
    • /
    • v.52 no.7
    • /
    • pp.1517-1523
    • /
    • 2020
  • The widely used medical isotope technetium-99 m (99mTc) is a daughter of Molybdenum-99 (99Mo), which is mainly produced using dedicated research reactors from the nuclear fission of uranium-235 (235U). 99mTc has been used for several decades, which covers about 80% of the all the nuclear diagnostics procedures. Recently, the instability of the supply has become an important topic throughout the international radioisotope communities. The aging of major 99Mo production reactors has also caused frequent shutdowns. It has triggered movements to establish new research reactors for 99Mo production, as well as the development of various 99Mo production technologies. In this context, a new research reactor project was launched in 2012 in Korea. At the same time, the development of fission-based 99Mo production process was initiated by Korea Atomic Energy Research Institute (KAERI) in 2012 in order to be implemented by the new research reactor. The KAERI process is based on the caustic dissolution of plate-type LEU (low enriched uranium) dispersion targets, followed by the separation and purification using a series of columns. The development of proper waste treatment technologies for the gaseous, liquid, and solid radioactive wastes also took place. The first stage of this process development was completed in 2018. In this paper, the results of the hot test production of fission 99Mo using HANARO, KAERI's 30 MW research reactor, was described.